An intraocular lens includes an optical portion and a support portion. The optical portion has an anterior optical plate portion and a posterior optical plate portion arranged on the anterior and posterior sides of the lens capsule. An optical body portion is arranged between the anterior optical plate portion and the posterior optical plate portion. The support portion has an outer support plate portion. An anterior support plate portion extends inwardly from an anterior end portion of the outer support plate portion and connects to a peripheral portion of an anterior optical plate portion of optical portion. A posterior support plate portion extends inwardly from a posterior end portion of the outer support plate portion and connects to a peripheral portion of a posterior optical plate portion of the optical portion. The anterior support plate portion and the posterior support plate portion extend inward and rearward or inward and forward.

A device having a structured coating for adhering to rough, in particular biological, surfaces, includes a carrier layer, wherein a plurality of protrusions is arranged on the carrier layer, which protrusions each comprise at least a shaft having an end face pointing away from the surface, and wherein a further layer is arranged at least on the end face, wherein the layer has a different modulus of elasticity than the protrusion in question. The further layer can also fill the intermediate spaces between the protrusions such that an internal structured coating is produced.

Prosthetic heart valve leaflet with a fixed end and a free end characterized by the fact that it has a variable thickness.

An artificial eye lens having an integral optical part which has, viewed in the direction of an optical principal axis of the eye lens, a first optical side and an opposite, second optical side. The optical part is formed with a structure having birefringence, where the birefringent structure in the integral optical part is formed as a laser structure. A method for producing an artificial eye lens, where the birefringent structure is produced with a laser apparatus, and a pulsed laser beam having a pulse length of between 100 fs and 20 ps, a wavelength of between 320 nm and 1100 nm, a pulse repetition rate of between 1 kHz and 10 MHz, a focus diameter of less than 5 μm, and a power density of greater than 10.sup.6 W/cm.sup.2.

A hair implant suitable for subcutaneous implantation is provided having an anchor comprising an anchor body, and at least one collagen receiving structure selected from the group consisting of at least one tunnel disposed through the anchor body and an external surface feature of the anchor body. The anchor further comprises at least one hair strand projecting from a distal end of the anchor body, wherein the at least one collagen receiving structure is configured to support collagen ligature growth after subcutaneous implantation of the hair implant so as to anchor the anchor to a hair implant recipient, and the collagen receiving structure is free of hair.

Apparatuses, systems and methods for providing improved ophthalmic lenses, particularly intraocular lenses (IOLs), include features for reducing dysphotopsia effects, such as haloes and glare. Exemplary ophthalmic lenses can include an optic having a central region disposed about an optical axis and a peripheral region extending outward from the central region, with a diffractive achromat positioned on the peripheral region, and the central region lacking an achromat, and a base power for distance of the central region being the same as a base power for distance of the peripheral region.

An intraluminal stent includes pluralities of first and second wire segments made from a soft malleable alloy formed into a cylindrical structure. Each of the wire segments is defined by a series of sinusoidal bends formed over the length of each segment, with the initial unformed length of each second wire segment being larger than that of each first wire segment. Each of the first and second wire segments include the same number of sinusoidal bends with the amplitude of the of the sinusoidal bends of the second wire segments being larger than that of the sinusoidal bends of the first wire segments. Adjacent wire segments are conjoined by welds at apices of each sinusoidal bend to form the cylindrical or tubular structure. The first wire segments can form a center portion of the stent and the second wire segments can be provided at either or both ends of the stent, enabling minimized axial shrinkage when the stent is radially expanded from an initial to an expanded diameter and in which the second wire segment at the terminal end of the stent is caused to outwardly flare significantly relative to the remainder of a radially expanded stent.

Described here are delivery devices for delivering one or more implants to the body, and methods of using. The delivery devices may deliver implants to a variety of locations within the body, for a number of different uses. In some variations, the delivery devices have a cannula with one or more curved sections. In some variations, a pusher may be used to release one or more implants from the cannula. In some variations, one or more of the released implants may be a self-expanding device. Methods of delivering implants to one or more sinus cavities are also described here.

Systems and methods for the manufacture of an hourglass shaped stent-graft assembly comprising an hourglass shaped stent, graft layers, and an assembly mandrel having an hourglass shaped mandrel portion. Hourglass shaped stent may have superelastic and self-expanding properties. Hourglass shaped stent may be encapsulated using hourglass shaped mandrel assembly coupled to a dilatation mandrel used for depositing graft layers upon hourglass shaped mandrel assembly. Hourglass shaped mandrel assembly may have removably coupled conical portions. The stent-graft assembly may be compressed and heated to form a monolithic layer of biocompatible material. Encapsulated hourglass shaped stents may be used to treat subjects suffering from heart failure by implanting the encapsulated stent securely in the atrial septum to allow blood flow from the left atrium to the right atrium when blood pressure in the left atrium exceeds that on the right atrium. The encapsulated stents may also be used to treat pulmonary hypertension.

Apparatuses, systems and methods for providing improved ophthalmic lenses, particularly intraocular lenses (IOLs). Exemplary diffractive intraocular implants (IOLs) can include a diffractive profile having multiple diffractive zones. The diffractive zones can include a central zone that includes one or more echelettes and a peripheral zone beyond the central zone having one or more peripheral echelettes. The central diffractive zone can work in a higher diffractive order than a remainder of the diffractive profile. The combination of the central and peripheral zones and an optional intermediate zone provides a longer depth of focus than a diffractive profile defined just by a peripheral and/or optional intermediate zone.